Accuray Incorporated (ARAY) Stock
Healthcare · Medical Devices · Member of Other US Stocks
Accuray Incorporated (ARAY) closed at USD 0.18 on 2026-10-14, a change of -87.8 % over the past year, with a market capitalization of USD 20.76M.
Accuray Incorporated recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 0.18 |
| 2026-10-13 | 0.19 |
| 2026-10-12 | 0.22 |
| 2026-10-09 | 0.23 |
| 2026-10-08 | 0.24 |
| 2026-10-07 | 0.25 |
| 2026-10-06 | 0.26 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Accuray Incorporated key figures
- Previous close
- USD 0.18 (2026-10-14)
- 1-year change
- -87.8 %
- Market cap
- USD 20.76M
- Enterprise value
- USD 164.01M
- P/E ratio (trailing)
- -0.47
- P/E ratio (forward)
- -0.72
- EPS (trailing)
- -0.37
- EPS (forward)
- -0.24
- PEG ratio
- 29.49
- Price to book
- 0.50
- Revenue growth
- -20.9 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 0.40
- Employees
- 809
- Analyst consensus (third-party)
- none
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Accuray Incorporated
Accuray Incorporated engages in the design, development, and sale of radiosurgery and radiation therapy systems for the treatment of tumors throughout the body in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, a tailored helical solution, which integrates radiation treatment planning, delivery, imaging, and data management; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Accuray Incorporated and compare it with other stocks.
Analyze ARAYAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Accuray Incorporated shares.